Correlation Engine 2.0
Clear Search sequence regions

  • antitumor (2)
  • cells (4)
  • dicumarol (2)
  • dicumarol (2)
  • dioxolanes (2)
  • drug antitumor (1)
  • growth (1)
  • heterografts (1)
  • humans (1)
  • lung (1)
  • mice (1)
  • oxygen (2)
  • species (2)
  • vitro (1)
  • Sizes of these terms reflect their relevance to your search.

    A series of novel ROS inducers were designed by merging the fragments of piperlongumine and dicoumarol. Most of these derivatives showed potent in vitro activity against three cancer cell lines and good selectivity towards normal lung cells. The most potent and selective compound 3e was proven to exhibit obvious ROS elevation and excellent in vivo antitumor activity with suppressed tumor growth by 48.46% at the dose of 5mg/kg. Supported by these investigation, these findings encourage further investigation around this interesting antitumor chemotype. Copyright © 2016 Elsevier Ltd. All rights reserved.


    Xiaojuan Xu, Xia Fang, Jun Wang, Hong Zhu. Identification of novel ROS inducer by merging the fragments of piperlongumine and dicoumarol. Bioorganic & medicinal chemistry letters. 2017 Mar 01;27(5):1325-1328

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 28159415

    View Full Text